IMMEDIATE FIT USING INNOVATIVE TECHNOLOGY PROSTHETIC SYSTEMS

使用创新技术假肢系统立即贴合

基本信息

  • 批准号:
    9339310
  • 负责人:
  • 金额:
    $ 95.48万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-09-01 至 2020-05-31
  • 项目状态:
    已结题

项目摘要

ABSTRACT The principal business interest, iFIT Prosthetics LLC ® with STTR funding, created a new transtibial prosthetic device and demonstrated its safety, comfort, and function. In contrast to conventionally made prosthetic limbs, the iFIT prosthesis is easily fit and aligned on the residual limb in a single session. Due to its substantial adjustability and customized inner liner, the iFIT device is a comfortable prosthesis that easily accommodates limb volume changes. Made of injection-molded, advanced polymer materials, it can be mass produced at a significant cost advantage compared to conventional devices. This Commercialization Readiness Pilot (CRP) program grant would come at a critical time for our business, as we are ready to accelerate large-scale commercialization for this unique prosthesis. This funding will allow us to develop processes and manufacturing procedures to fully comply with regulations for sales to the Centers for Medicare and Medicaid Services (CMS), the Veterans Affairs (VA) Health systems, private insurers, and prosthetists. We will complete international standards (ISO 10328) testing for the production devices. We will expand and refine our business capabilities by making new socket sizes and shapes to fit a broader range of patients with both transtibial and transfemoral limb loss. A prospective two-month clinical trial with 40 subjects will be conducted to compare the iFIT prosthesis to conventional devices. To enhance market acceptance, we will refine the inner liner and enhance the outer socket appearance. Our close collaboration with Advanced Design Concepts (ADC) and its engineering team has been highly successful in developing this product. ADC has the manufacturing capabilities to produce the iFIT prosthesis commercially. iFIT Prosthetics is on the cusp of commercializing a completely unique new type of prosthesis. The modular and mass produced nature of this new adjustable device holds great promise for improving access to affordable prosthetics and enhancing the quality of life for persons with lower limb amputations in the United States and internationally.
摘要 主要的商业利益,iFIT Prosthetics LLC ®与STTR的资金,创造了一个新的经胫骨假体 设备,并证明其安全性,舒适性和功能。与传统的假肢相比, iFIT假肢可在单次手术中轻松安装并对准残肢。由于其巨大的 iFIT装置具有可调节性和定制内衬,是一种舒适的假体, 肢体体积变化。它由注塑成型的先进聚合物材料制成,可以以 与传统设备相比具有显著的成本优势。商业化准备试点(CRP) 计划拨款将在我们业务的关键时刻到来,因为我们准备加速大规模的 这一独特的假体的商业化。这笔资金将使我们能够开发流程, 制造程序完全符合向医疗保险和医疗补助中心销售的规定 服务(CMS),退伍军人事务部(VA)卫生系统,私人保险公司和假肢。我们将完成 生产设备的国际标准(ISO 10328)测试。我们将扩大和完善我们的业务 通过制造新的关节窝尺寸和形状,以适应更广泛的经胫骨和 经股截肢将进行一项为期两个月的前瞻性临床试验, iFIT假体与传统器械相比。为了提高市场的接受度,我们将改进内衬, 增强外插座外观。我们与先进设计概念(ADC)及其 工程团队在开发这种产品方面非常成功。ADC拥有制造 商业化生产iFIT假体的能力。iFIT Prosthetics正处于商业化的风口浪尖, 一种全新的假肢这款新型可调节的模块化和批量生产的特性 该设备为改善获得负担得起的假肢和提高生活质量带来了巨大的希望, 美国和国际上的下肢截肢者。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(6)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TIMOTHY R DILLINGHAM其他文献

TIMOTHY R DILLINGHAM的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TIMOTHY R DILLINGHAM', 18)}}的其他基金

Evaluating a Comprehensive Multimodal Outpatient Rehabilitation Program to Improve the Functioning of Persons Suffering from Post-acute Sequelae of SARS-CoV-2 infection (PASC): A Randomized Controlled
评估综合多模式门诊康复计划以改善 SARS-CoV-2 感染急性后遗症患者的功能 (PASC):一项随机对照研究
  • 批准号:
    10583969
  • 财政年份:
    2023
  • 资助金额:
    $ 95.48万
  • 项目类别:
Adjustable prosthetic sockets for children and adolescents with lower limb loss to accommodate growth
为下肢缺失的儿童和青少年提供可调节假肢接受腔以适应生长
  • 批准号:
    10658207
  • 财政年份:
    2022
  • 资助金额:
    $ 95.48万
  • 项目类别:
Adjustable prosthetic sockets for children and adolescents with lower limb loss to accommodate growth
为下肢缺失的儿童和青少年提供可调节假肢接受腔以适应生长
  • 批准号:
    10382682
  • 财政年份:
    2021
  • 资助金额:
    $ 95.48万
  • 项目类别:
Evaluating the Effects of CMS' Prospective Episode-Based "Bundling" Payment Model for Lower Limb Joint Replacement: Post-acute Care Setting, Costs and Patient Outcomes
评估 CMS 基于前瞻性事件的“捆绑”支付模式对下肢关节置换的效果:急性后护理环境、成本和患者结果
  • 批准号:
    10217952
  • 财政年份:
    2018
  • 资助金额:
    $ 95.48万
  • 项目类别:
Evaluating the Effects of CMS' Prospective Episode-Based "Bundling" Payment Model for Lower Limb Joint Replacement: Post-acute Care Setting, Costs and Patient Outcomes
评估 CMS 基于前瞻性事件的“捆绑”支付模式对下肢关节置换的效果:急性后护理环境、成本和患者结果
  • 批准号:
    9982744
  • 财政年份:
    2018
  • 资助金额:
    $ 95.48万
  • 项目类别:
IMMEDIATE FIT USING INNOVATIVE TECHNOLOGY TRANSTIBIAL PROSTHESIS
使用创新技术的胫骨假体立即贴合
  • 批准号:
    9134601
  • 财政年份:
    2015
  • 资助金额:
    $ 95.48万
  • 项目类别:
Immediate fit using innovative technology transtibial prosthesis
使用创新技术的小腿假体立即贴合
  • 批准号:
    8393054
  • 财政年份:
    2011
  • 资助金额:
    $ 95.48万
  • 项目类别:
Immediate fit using innovative technology, transtibial prosthetic system
使用创新技术、经胫骨假肢系统立即贴合
  • 批准号:
    8122693
  • 财政年份:
    2011
  • 资助金额:
    $ 95.48万
  • 项目类别:
Immediate fit using innovative technology, transtibial prosthesis
采用创新技术的即时贴合,经胫骨假体
  • 批准号:
    8551681
  • 财政年份:
    2011
  • 资助金额:
    $ 95.48万
  • 项目类别:
Guitars for Vets: Evaluating psychological outcomes of a novel music therapy
退伍军人吉他:评估新型音乐疗法的心理结果
  • 批准号:
    8002687
  • 财政年份:
    2010
  • 资助金额:
    $ 95.48万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 95.48万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 95.48万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 95.48万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 95.48万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 95.48万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 95.48万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 95.48万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 95.48万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 95.48万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 95.48万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了